A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
SirenWired
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

#SocPharm Tweetchat Transcript 7/13/2011

Posted by | 11:38pm on Wednesday, July 13, 2011

:
Id like to welcome everyone to this week’s #socpharm chat moderated by myself and my galaxy tablet. Please introduce yourselves!

:
Hi @: Thanks for moderating #socpharm this week.

:
Ill start off. My name is dan sfera and I run a blog where we attempt to demystify clinical tri ada ls. #socpharm

:
Clinical trials #socpharm

:
T1: according to @ bayer recently got into trouble for tweeting about some of their meds. Any pharma implications? #socpharm

:
@: Are you talking about the concern in UK? http://ow.ly/5E2L8 #socpharm

:
@: here from Novo Nordisk. #socpharm

:
@: yes it occured in the UK. #socpharm

:
@: welcome to #socpharm craig!

:
@: Nice you use SGT. Better than iPad (for work) yes? :-) #socpharm

:
Account was @ so clear focus on that auidence. Only US & NZ have DTC ads so unsurprising they had issue #socpharm

:
@: yea although im sure ipads run smoother. #socpharm

:
T1: I get impression that they were using tweets as PR vs promo but that not smart. #socpharm

:
Could this impact the way pharma will tweet in the fututre? #socpharm

:
@: True but so do MacBooks but what does biz use, PCs. Go figure. :-) #socpharm

:
Ok. Topic 2: facebook will soon force fan pages to allow comments. Will pharma give in or will they abandon? #socpharm

:
T1: I think it calls out the multinational hazards of social media. It takes extra thought and planning to avoid such. #socpharm

:
T1 I think companies will certainly think about mentioning a brand in a tweet in future. #socpharm

:
T2: What would the nature of pharma give in be? #socpharm

:
RT @: : Ok. Topic 2: facebook will soon force fan pages to allow comments. Will pharma give in or will they abandon? #socpharm

:
T1: I know they are already thinking about this which is why so few do. #socpharm

:
@: I guess basically engaging in actual conversations if appropriate. #socpharm

:
R. Kempton-brand planning at a phrma mkting agency. Wish 2 know opinion abt how 2 handle nervous client re:social media listening? #socpharm

:
#socpharm I’m Valentina. Work with clinical trials in LatAm :) Trying to follow from bb.

:
@: welcome! Hope someone can help. #socpharm

:
t2: This is not an matter of giving in but of adapting. I think FB will find way not to lose business. There are a # of options. #socpharm

:
@: Check these tips on new media adoption. http://www.slideshare.net/cadelarge: /reflections-on-new-media-adoption #socpharm

:
@ welcome my friend! #socpharm

:
Sharing this article on Bayers problems in the UK re: tweeting. Thks to @: for the link http://t.co/6fZ1AO6 #socpharm #hcsm

:
T2 Yes this is forcing some brands/companies to engage on FB but some will choose not to. #socpharm

:
@: yes but facebook feels pretty strongly about tbis. #socpharm

:
lurking whilst at work… from Wellington NZ #socpharm

:
@: What are they nervous about? If it’s adverse events can you go through their training & report any as usual? #socpharm

:
@: loving it! #socpharm

:
@: Thanks for saying hello! Think you qualify as farthest participant :) #socpharm

:
@: Strong feelings & adaptation arent antithetical. :-) Moderated comments & exceptions are 2 opts I have heard of. #socpharm

:
RT @: : @: Check these tips on new media adoption. #socpharm http://ow.ly/5E37F

:
Agreed pharma will have to adapt, albeit slowly. #socpharm

:
@: just don’t tell my boss haha #socpharm

:
RT @: : RT @: : @: Check these tips on new media adoption. #socpharm http://ow.ly/5E37F #socpharm

:
@: Some will some not. Many probably should not bother. :-) #socpharm

:
comments come as a double edged sword, its the reaction to the comments that will be the true acid test #socpharm

:
SM is about a conversation, and if you aren’t going to “converse” then pharma should think twice about why they are using it #socpharm

:
T3: with google health shutting down what will happen to all the health records? Anyone know? #socpharm

:
@: Their legal dept haven’t come 2 an agreed “position” regarding AE’s. we’re advocating a ‘listening’ tool only #socpharm.

:
Sometimes people forget that we aren’t engaging around a soda or sneaker but serious medications, it’s complicated & takes time #socpharm

:
@: who owns that data now? even if patients access it all, will it be removed from Google servers? #socpharm

:
@: yes social media is conversation not marketing like some industry folks think. #socpharm

:
Hi all. Frieda Hernandez from Siren Interactive joining #socpharm #socpharm

:
RT @: : Sometimes people forget that we aren’t engaging around a soda or sneaker but serious medications, it’s complicated & takes time #socpharm

:
@: exactly@ maybe SM night not be the correct channel. the channel should be dictated by the message being conveyed? #socpharm

:
@: There ARE guidelines on what’s a reportable AE. Can’t u follow those & if u hear anything follow normal process? #socpharm

:
@: welcome frieda #socpharm

:
RT @: : Sometimes pple forget we arent engaging around soda or sneaker but serious meds, its complicated, takes time #socpharm

:
@: Thanks, Dan #socpharm #socpharm

:
@: @: have no idea. Google must still own it. #socpharm

:
@: thanks Dan! #socpharm

:
RT @: : T3: with google health shutting down what will happen to all the health records? Anyone know? #socpharm

:
@ SM is about meeting customer needs & convo is not the only way to go about it. Check this: http://bit.ly/lsMQ7M #socpharm

:
@: Thks Eileen. What gdlines are you referring too? Not from FDA? #socpharm

:
Good ? RT @: : T3: with google hlth shutting down what will happen to the hlth records? Anyone know? @? #socpharm

:
@: See details about Google Health going away http://ow.ly/5E3nO #socpharm

:
RT @: : @: See details about Google Health going away http://ow.ly/5E3nO #socpharm

:
@: Yes, the FDA has general guidelines on what makes a reportable Adverse Event. Not specific to social media. #socpharm

:
Can download Google Health info through Jan 1, 2013. After that wonder if they will destroy it? #socpharm

:
So right! RT @: : SM is abt meeting customer needs & convo is not the only way 2 go abt it. Check this http://bit.ly/lsMQ7M #socpharm

:
They’ll be deleted after Jan 2013RT @: : T3: what will happen to all the health records? #socpharm http://bit.ly/oZMH0N

:
@: I doubt they will destroy it. Google has so much data on everyone even beyond health. Hope they never get shady #socpharm

:
Guess a little bit of Google’s hubris around their power to “change health” is gone. #socpharm

:
They say they’ll delete it in 2013. Do no evil? RT @: : @: Hope they never get shady #socpharm http://bit.ly/oZMH0N

:
T4: staying with google, once google plus allows companies on, will anyone actual follow a pharma co after dull fanpages on fb? #socpharm

:
Thnx RT @: : Theyll be deleted after 1/13 re: what will happen to all the hlth records? http://bit.ly/oZMH0N #socpharm

:
It’s 2 complicated. RT @: : Guess a little bit of Googles hubris around their power to “change health” is gone. #socpharm

:
T4: Yes, as the market will only further fragment. There are those deep into FB who will not every go G+, at least not primarily. #socpharm

:
I guess the engagement issue wont go away regardless of the social platform. #socpharm

:
Dialog is powerful RT @: : I guess the engagement issue wont go away regardless of the social platform. #socpharm

:
@: yes I see niche opportunities within pharma divisions for goog plus. Small is yhe new big, smurf it ip! #socpharm

:
Pharma Virtual Summit: Successful #Healthcare #Content via Social #Media http://t.co/2QfFNIm #socpharm #hcsmeu #hcsm

:
Lol smurf it up! #socpharm

:
@: Not all FB pharma pages are “dull”! Some, (Psoriasis360) provide valuable info & others (BI) enage via contests. #socpharm

:
Right. G+ synchs many virtual activities? Will pharma be able to create a deep, authentic enough presence? RT @: #socpharm

:
RT @: : Pharma Virtual Summit: Successful #Healthcare #Content via Social #Media http://t.co/2QfFNIm #socpharm #pharma

:
@: lol I know just a little link baiting on my part. Or tweet baiting? #socpharm

:
But I do see opportunities for pharma to provide specific niche content through fragmented goog plus pages #socpharm

:
@: I’m looking forward to understanding it fuller when Google+ allows business pages. #socpharm

:
Me 2 RT @: : @: Im looking forward to understanding it fuller when Google+ allows business pages. #socpharm

:
@: @: yes I think niche profiles will be HUGE in 2012! #socpharm

:
Gd preso RT @: : Pharma Virtual Summit: Successful #Healthcare #Content via Social #Media http://t.co/2QfFNIm #socpharm#socpharm

:
Gotta run. Have a blessed week all! #socpharm

:
Likewise, Craig. RT @: : Gotta run. Have a blessed week all! #socpharm

:
Always wanted to host one of these, thanks guys! #socpharm

:
Thanks to @: for guest moderating #socpharm tonight. In two weeks @ will be taking the reigns.

:
I’ll let everyone know when I post the transcript. #socpharm

:
@: You did an excellent job. Very stimulating convo. #socpharm

:
@: Thanks, Eileen and great to chat with everyone. #socpharm

:
Thanks for my first #socpharm chat @: @: @: @

:
RT @: : Sometimes people forget that we aren’t engaging around a soda or sneaker but serious medications, it’s complicated & takes time #socpharm

:
And thank you too RT @: : Thanks for my first #socpharm chat @: @: @: #socpharm

:
And a nice chat with the Aussie w the mic @ and her new #socpharm sidekick @ – hope to see #bdi1 crowd again soon!

:
Thanks to @: & @: for this evenings #socpharm chat

About Eileen O'Brien

Eileen has more than 16 years of digital healthcare marketing experience. She is an opinion leader on social media and biopharma, and has been invited to speak at industry conferences and quoted in publications.

View other posts from Eileen

Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com